openPR Logo
Press release

Integrin Beta 3 Key Players – Factor Therapeutics Ltd, Merck & Co Inc, SciFluor Life Sciences LLC and SOM Biotech SL Analysis & Forecast 2018 to 2022

02-19-2018 10:53 AM CET | Health & Medicine

Press release from: WiseGuy Research consultants Pvt Ltd.

/ PR Agency: WISEGUY RESEARCH CONSULTANTS PVT LTD
Integrin Beta 3

Integrin Beta 3

Integrin Beta 3

Overview

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) pipeline Target constitutes close to 20 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes.

The latest report Integrin Beta 3 - Pipeline Review, H1 2018, outlays comprehensive information on the Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2966997-integrin-beta-3-platelet-membrane-glycoprotein-iiia-or-cd61-or

Top Companies mentioned

Factor Therapeutics Ltd

Merck & Co Inc

SciFluor Life Sciences LLC

SOM Biotech SL

Vascular Pharmaceuticals Inc

VDDI Pharmaceuticals

Integrin Beta 3 Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Integrin Beta 3 - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Integrin Beta 3, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) - Integrin beta-3 (β3) or CD61 is a protein that in humans is encoded by the ITGB3 gene. Integrin beta 3 is found along with the alpha IIb chain in platelets. It is a receptor for cytotactin, fibronectin, laminin, matrix metalloproteinase-2, osteopontin, osteomodulin, prothrombin, thrombospondin, vitronectin and von Willebrand factor. Activation of integrin alpha-IIb/beta-3 leads to platelet interaction through binding of soluble fibrinogen.

This leads to rapid platelet aggregation which physically plugs ruptured endothelial surface. The molecules developed by companies in Phase II, IND/CTA Filed, Preclinical and Discovery stages are 3, 1, 8 and 1 respectively.

Integrin Beta 3 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Integrin Beta 3 - Competitive Analysis

Key players are making innovative developments in Integrin Beta 3 industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Integrin Beta 3.

The pipeline guide reviews pipeline therapeutics for Integrin Beta 3 by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Integrin Beta 3 therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Integrin Beta 3 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Integrin Beta 3.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2966997-integrin-beta-3-platelet-membrane-glycoprotein-iiia-or-cd61-or

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Integrin Beta 3 Key Players – Factor Therapeutics Ltd, Merck & Co Inc, SciFluor Life Sciences LLC and SOM Biotech SL Analysis & Forecast 2018 to 2022 here

News-ID: 948151 • Views:

More Releases from WiseGuy Research consultants Pvt Ltd.

Beauty Drinks Market and its Future Outlook and Trend During the Period of 2019 – 2025
Beauty Drinks Market and its Future Outlook and Trend During the Period of 2019 …
Global Beauty Drinks Market Research Report 2019 Summary: - Wiseguyreports.Com Adds “Beauty Drinks - Market Demand, Growth, Opportunities, Manufacturers and Analysis of Top Key Players to 2025” To Its Research Database. Overview: Beauty drinks refer to both carbonated and non-carbonated beverages, which is used to retain natural beauty during aging. The beauty drinks contain various vitamins, minerals, amino acids, and antioxidants. It aids to support diets by encouraging metabolism. The global beauty drinks market
Global Capsule Endoscopy Treatment Solutions Market 2020: key Vendors, Trends, A …
Summary A New Market Study, titled “Capsule Endoscopy Treatment Solutions Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports. This report provides in depth study of “Capsule Endoscopy Treatment Solutions Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Capsule Endoscopy Treatment Solutions Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such
Data Center Colocation Market 2019: Size, Share, Demand, Trends, Growth and 2025 …
Global Data Center Colocation Industry New Study On “2019-2025 Data Center Colocation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database Data center operators face an increasing need for scalable data center infrastructure, which enables the scaling of critical data center components as and when the demand increases. The data center colocation provides data center space, along with the power and cooling infrastructure, which address
Temperature Logger Market 2019 Trends, Research, Analysis & Review Forecast 2025
Global Temperature Logger Industry New Study On “2019-2025 Temperature Logger Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database This report studies the global Temperature Logger market status and forecast, categorizes the global Temperature Logger market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The

All 5 Releases


More Releases for Integrin

Integrin Beta Market 2021 Size, Growth Analysis Report, Forecast to 2027
The global integrin beta market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Integrins are proteins that function mechanically. They attach to the cell cytoskeleton to the extracellular matrix (ECM), and biochemically through sensing if adhesion has occurred. The integrin family consists of two types of protein including alpha and beta subtypes. Additionally, there are 8 types of integrin beta-protein such as IGBT1, IGBT2, IGBT3,
Human Integrin Beta 3 Market: Competitive Dynamics & Global Outlook 2020-2025
Human Integrin Beta 3 This report also researches and evaluates the impact of Covid-19 outbreak on the Human Integrin Beta 3 industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Human Integrin Beta 3 Maker and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). Market Overview The Human Integrin Beta 3 Maker market report provides a detailed analysis of global market
Human Integrin Beta 3 Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Human Integrin Beta 3 market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Human Integrin Beta 3market by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Human Integrin Beta 3market, market definition,
Integrin Beta3 Protein Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Integrin Beta3 Protein market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Integrin Beta3 Proteinmarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Integrin Beta3 Proteinmarket, market definition, overview, industry opportunities
Human Integrin Beta3 Antibody Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Human Integrin Beta3 Antibody market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Human Integrin Beta3 Antibodymarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Human Integrin Beta3 Antibodymarket, market definition,
Integrin Beta 3 Market To Observe Strong Development through H1 2018
Overview Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) pipeline Target constitutes close to 20 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. The latest report Integrin Beta 3 - Pipeline Review, H1 2018, outlays comprehensive information on the Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) targeted therapeutics, complete with analysis by indications, stage of development,